Please try another search
For the nine months ended 31 March 2015, Elder Pharmaceuticals Ltd revenues decreased 42% to RS5.13B. Net loss increased 88% to RS1.76B. Revenues reflect Other Operating Income decrease of 14% to RS46.3M. Higher net loss reflects Other Income decrease of 52% to RS113.1M (income), Depreciation and Amortization expense increase of 3% to RS306.7M (expense).
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Revenue | 1520.63 | 1579.26 | 2031.38 | 1202.25 |
Gross Profit | 564.82 | 501.3 | 696.75 | -561.13 |
Operating Income | -217.38 | -394.53 | -328.64 | 2143.87 |
Net Income | -460.22 | -835.63 | -468.73 | 872.92 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Assets | 18637.81 | 22881.96 | ||
Total Liabilities | 11613.97 | 15148.47 | ||
Total Equity | 7023.84 | 7733.49 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review